Mark N. Lampert, 10% Owner at LIGAND PHARMACEUTICALS INC (LGND), bought 75,353 shares at $13.69 ($1.0M) on 2011-10-12, disclosed to the SEC on 2011-10-14.
Open-market purchase of $1.0M LGND by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.69 | 5,600 | $77K | 7.5% |
| 2 | $13.69 | 11,300 | $155K | 15.0% |
| 3 | $13.69 | 36,200 | $496K | 48.2% |
| 4 | $13.55 | 3,020 | $41K | 4.0% |
| 5 | $13.55 | 4,995 | $68K | 6.6% |
| 6 | $13.55 | 14,238 |
| $193K |
| 18.8% |
| Total | $13.65 avg | 75,353 | $1.0M | 100% |
| Filing → |
| MRUS | BUY | 2021-03-18 | $5.8M | — | Filing → |
| XOMA | BUY | 2019-12-20 | $8.2M | — | Filing → |
| CALA | BUY | 2019-11-22 | $1.5M | — | Filing → |